SSRI Antidepressant Lawsuit Funding
Attorneys or plaintiffs involved in lengthy SSRI antidepressant litigation can be faced with serious cash-flow problems. RD Legal Funding can help by converting settled cases into cash with their proprietary Fee Acceleration post-settlement funding program. Fill out the brief application to the right to become eligible for a free consultation with a legal funding specialist. Or, call 1-800-565-5177 to speak with a Fee Acceleration expert.
SSRI Antidepressant Litigation
SSRIs — selective serotonin reuptake inhibitors — are the most commonly prescribed compounds for the treatment of depression, anxiety disorders, and some personality disorders. According to the Mayo Clinic, by blocking the reabsorption of the neurotransmitter serotonin, they help brain cells send and receive chemical messages, boosting one’s mood. These are the most common SSRIs:
- Citalopram (Celexa)
- Escitalopram (Lexapro)
- Fluoxetine (Prozac, Sarafem)
- Paroxetine (Paxil, Pexeva)
- Sertraline (Zoloft)
- Fluvoxamine (Luvox)
SSRIs were widely touted as being harmless. Then a series of studies and high profile cases linked their use with increased thoughts of violence and suicidal thoughts among teens and young adults. The U.S. Food and Drug Administration (FDA) issued a public warning in 2004, cautioning against prescribing SSRIs to children and adolescents. An FDA advisory committee recommended extending the warning to young adults up to the age of 25. In 2007, a black box warning label was added to the drugs.
A Massachusetts class action lawsuit against Celexa’s manufacturer, Forest Pharmaceuticals, maintains that the company used false and misleading marketing, and paid doctors to prescribe the drug to children and adolescents. A Missouri class action lawsuit consisting of 42 different cases claims that Celexa caused suicide or suicidal thoughts.
Prozac’s manufacturer, Pfizer, has also been the object of lawsuits. The parents of Ed Harris, one of the Columbine High School shooters, claim their son became obsessed with violent and suicidal thoughts within weeks of starting to take Zoloft.
A study recently published in The New England Journal of Medicine found that pregnant women taking SSRIs in their third trimester delivered babies who were six times more likely than babies not exposed to SSRIs to have persistent pulmonary hypertension of the newborn (PPHN) or develop primary pulmonary hypertension (PPH). Other studies found that taking SSRIs at all stages of pregnancy increased the risks of heart defects, limb deformities, diabetes, and autism. As of April 2013, over 300 SSRI birth defect lawsuits have joined forces. On May 2, 2013 a federal judge declared there are now enough lawsuits to move forward with Zoloft birth defect litigation.
RD Legal Provides Post-Settlement Attorney Funding
The legal battles surrounding SSRIs are sure to be long and involved. Settlement funding can help attorneys working on a contingency basis or plaintiffs burdened by the death or injury of loved ones. As soon as settlement amounts are determined, fill out the brief online application located in the upper right corner of this page. Or call RD Legal toll-free at 1-800-565-5177 today to discuss your financial options with one of our legal funding experts.